68Ga-FAPI-04 PET/CT Imaging for Fibrous Dysplasia of the Bone.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34507335.
- Also identified by DOI 10.1097/RLU.0000000000003896.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
68Ga-labeled quinoline-based fibroblast activation protein inhibitors (68Ga-FAPIs) are promising agents for tumor imaging. However, some nonneoplastic lesions can also cause increased FAPI uptake. We report a case of a patient with polyostotic fibrous dysplasia who showed widespread and intense metabolic activity on 68Ga-FAPI PET/CT. Physicians should be aware that fibrous dysplasia can also cause elevated FAPI activity.
Medical subject headings
- Fibrous Dysplasia of Bone
- Neoplasms
- Quinolines